• 
• http://www.nature.com/pcan
• Editor: Professor Roger Kirby and Judd W. Moul, MD
• Volume 12: 4 issues per year
• ISSN: 1365-7852
• EISSN: 1476-5608
• Impact factor : 2.024*
• Impact ranking: 25/55 in Urology and Nephrology, 88/132 in Oncology*
• Date Established: 1997
• Published on behalf of:

Aims and Scope:
Prostate Cancer and Prostatic Diseases publishes papers on all aspects of prostatic diseases. The journal reports on exciting developments in diagnosis, surgery, radiotherapy, drug discovery and medical management. Topics include screening, radiation, therapy, epidemiology, hormone therapy, molecular biology and genetics, gene therapy, biochemical markers, new technologies, prognostic indicators, chemotherapeutics, treatment options and immunological approaches.

Readership:
Clinicians and researchers treating all aspects of the prostate, including urologists and oncologists.

Online features and site license access:

• Online archive available back to September 1997.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content is freely available after five years.
• Indexed in Medline (PubMed), EMBASE, Current Contents Clinical Medicine, Research Alert, SciSearch, SciExpanded, Science Citation Index and UK Health Centre Index.

*2007 Journal Citation Report (Thomson Reuters, 2008)